| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Alju02g0844 | ATGGAGGTTTTCATGTCAAGCTCTAAACCTGCCTCTGTTTCTTTCTTCGGATTTCTGCTTCTCTGTTTCTTCACTGATTTCCCATCAAAAGCTCAACTCATACCCCCATATGAAGTGAAGGTATTGCAGGCAATATCAGATAAACTCAAAAATGTGAATTGGAAGGTGACGCAAACATCTTGTAGGACAGGGCTTGGATTTAATCAGTTCACTCAGACTTCTGAAATCACAAGGAATGTCACTTGCAATTGCACTTTCCAAAACGGCGCCGTTTGCCACGTCACTCATATTCTGTTGAAAAGCCAAAATATATCAGGAGAAATACCCAGTGAATTTGGAAACCTCACCCATCTCACTCAACTTGATTTTTCTCTCAACTATCTCAATGGCGCCATTCCAACGTCTTTGATGCGCATCCCTCTTGTCAACTTGTCCCTCGTGGGGAATGGTATCGATGGTTCAATTCCCTCAGAATTAGGTGAAATTAGTAGTCTGCAGGAGCTGATCCTAGAAGATAATCAGCTTGGAGGAATTCTTCCTCGTAGTCTTGGAAATTTGAACAACCTGCGAAGATTACGTCTTTCTGCAAATAATTTTACTGGGACAATGCCAGATACGTTTGGGAATCTAAAGAACCTAACTGAGTTTTCGTTGGATGGAAGCAGCTTATCAGGAAAGATACCAAGTTTTATTGGGAATTGGACCTCAATTGTTTACTTGGATATGCAAGGCACAGGTATGGAAGGCCCAATTCCTCCCACCATATCCTTGTTGACAAATCTGATAGAATTGAGACTATCCGATTTGAGTGGCACAACAGCTATGAAATTTCCTGATCTAGGGAATTTGATGAGCTTGCAACGACTGATATTGAGAAATTGCTTAATTACTGGTCCCATTCCAAAGTACATTGGTCAAATGAAAAACTTAAAGACTCTGGACTTGAGTTTTAACAACTTGACTGATTCAATCCCTGTCTCGTTTCAAGACTTGAATTTTAATCACATGTTTCTTACAAACAATTCTCTGAGTGGAACAGTTCCAGAATGGGTGCTCAAGAACAAATATAATATTGATTTATCTTACAACAATTTTACTGAGGCTTCTACATCTACCTGCCAGGTCTTGGAAGTGAACTTGGCTTCTAGCCTCTCATCTTCAGCAAGCAATCCACTCCTTTGTCTGAAGAAAGGCCTGCCATGTGCAGGAAAGCCTCAATATTATTCATTATTCATAAATTGTGGAGGAACCAAGATGAAGTATGAGGGGAATGAATATGAGGAAGATCTCAATAAAGATGGAACTTCATTCTTTGATCAAAAAGACAAATGGGCTTATAGCAGCACAGGAACATATATATACAATGATAAAGCTGATTATGTAGCTAGTCTAGCAACTTCGAATCTTAATGACTCAAAGTACTACCAAACAGCCCGCCTTAGCCCACTGTCACTTAAGTATTATGGCTTATGTATGATGAAGGGCAATTATAAAGTAAAGCTCCATTTTGCTGAGATAATGTTTTCTGATGACCAGACATTTAGCAGCCTTGGCAGACGCATATTTGATGTTTCCATTCAAGGTATTAAATACTTGAAAGATTTTAACATTGCGGAGGAAGCTGGTGGAGTTGGTAAGGGCATCACTAAGGTATATGATGTTGATGTGAATGATAGCACCTTGGAGATGCATTTATATTGGGCAGGGAAAGGTACTACAGCTATTCCCACTAGAGGTGTATATGGACCTCTAATTTCTGCTATCACTGTGACCCCAAACTTCAAAGTTCCTTCACAAGGGTTGTCTGCCGGAGCTATCGTTGGAATTGTGGTTGGATTATGTTTATTCCTCATACTAGTGGTACTAATTATTATCCTCCGAATGAATGGTTTCCTTGGTGGCAAAGATCCTCAAGACATAGATCTTAAGGGTTTGGATCTTAAAACTGGTATGTTTACCTTAAAGGAAATCAAAGCAGCAACCAACAACTTCAATGCTGATAATAGGATCGGAGAAGGAGGGTTTGGTCCTGTTTTTAAGGGCGTTCTCCCAGATGGCAGAATAATTGCAGTTAAGAAGCTATCTGCTAAATCAAGGCAAGGGAATCGTGAATTTCTAAATGAAGTAGGCATGATTTTTGCTTTGCAACACCCTTGCCTTGTTAAGCTTTATGGCTGTTGTGTTGAAGGAGATCAATTGTTGCTCGTATACGAGTTTATGGATAACAATAGCCTTGCTCGCGCTTTATTTGGCCCAGAAGAATTCCAGTTAAAATTGGAGTGGCCAACTAGACACAAGATTTGTGTTGGGATTGCTAGAGGTTTGGTTTACCTTCACGAAGAATCAAGATTTAAAATTGTTCATAGAGACATCAAGGCCTCTAATGTATTGCTTGATAAAGAACTCAACCCCAAGATTTCTGATTTTGGTTTGGCCAAGCTTTATGAGGAGGAAAATACACATATTAGCACTAGAATTGCTGGAACTCGCGGTTACATGGCTCCTGAATATGCAATGCATGGATATTTGACCAAGAAAGCAGATGTTTATAGTTTTGGGATTGTTGTTTTAGAAATTATCAGTGGCAAGACCAACACCACTCAAAAGTCAGAGGAAGAATGTTTTTATTTGCGTGATTGGGCACATCAGTTGAAAGATGAAAATCATCTTATGGATATGGTGGATCCAAAGTTGGGTGAGGACTTTAACAGAGAGGAAATAATGACTGTGATAGATGTGGCTGTCCAATGCACTGAAAACTCCCCAGCACTTAGGCCTACCATGACTAAAGTGCTTAGCATTCTTGAAGGAAGGCCTTCTGTTCAGGAGGTAGTCTCAGATGATGAAAGTGAGATTATTATGGATGATGAATTGAAATTGACCAAGAAACAAGAAGCTGATGAAGATCAGACTGATCAGGCCATAAACTCGTCAAGCCTTGAGTCTCAGACCACATCTAAATCCTTTTCAGATCTCTATCCGGCCAATAAAGATTCTTCTTTCTGGCACAAAACCAACTAG | 3021 | 0.3979 | MEVFMSSSKPASVSFFGFLLLCFFTDFPSKAQLIPPYEVKVLQAISDKLKNVNWKVTQTSCRTGLGFNQFTQTSEITRNVTCNCTFQNGAVCHVTHILLKSQNISGEIPSEFGNLTHLTQLDFSLNYLNGAIPTSLMRIPLVNLSLVGNGIDGSIPSELGEISSLQELILEDNQLGGILPRSLGNLNNLRRLRLSANNFTGTMPDTFGNLKNLTEFSLDGSSLSGKIPSFIGNWTSIVYLDMQGTGMEGPIPPTISLLTNLIELRLSDLSGTTAMKFPDLGNLMSLQRLILRNCLITGPIPKYIGQMKNLKTLDLSFNNLTDSIPVSFQDLNFNHMFLTNNSLSGTVPEWVLKNKYNIDLSYNNFTEASTSTCQVLEVNLASSLSSSASNPLLCLKKGLPCAGKPQYYSLFINCGGTKMKYEGNEYEEDLNKDGTSFFDQKDKWAYSSTGTYIYNDKADYVASLATSNLNDSKYYQTARLSPLSLKYYGLCMMKGNYKVKLHFAEIMFSDDQTFSSLGRRIFDVSIQGIKYLKDFNIAEEAGGVGKGITKVYDVDVNDSTLEMHLYWAGKGTTAIPTRGVYGPLISAITVTPNFKVPSQGLSAGAIVGIVVGLCLFLILVVLIIILRMNGFLGGKDPQDIDLKGLDLKTGMFTLKEIKAATNNFNADNRIGEGGFGPVFKGVLPDGRIIAVKKLSAKSRQGNREFLNEVGMIFALQHPCLVKLYGCCVEGDQLLLVYEFMDNNSLARALFGPEEFQLKLEWPTRHKICVGIARGLVYLHEESRFKIVHRDIKASNVLLDKELNPKISDFGLAKLYEEENTHISTRIAGTRGYMAPEYAMHGYLTKKADVYSFGIVVLEIISGKTNTTQKSEEECFYLRDWAHQLKDENHLMDMVDPKLGEDFNREEIMTVIDVAVQCTENSPALRPTMTKVLSILEGRPSVQEVVSDDESEIIMDDELKLTKKQEADEDQTDQAINSSSLESQTTSKSFSDLYPANKDSSFWHKTN | 1006 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Alju02g0844 | 1006 | ProSiteProfiles | Protein kinase domain profile. | 664 | 941 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Alju02g0844 | 1006 | MobiDBLite | consensus disorder prediction | 961 | 1006 | - | - | |
| Alju02g0844 | 1006 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 740 | 947 | - | - | |
| Alju02g0844 | 1006 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 18 | 976 | - | - | |
| Alju02g0844 | 1006 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 786 | 798 | IPR008271 | GO:0004672|GO:0006468 | |
| Alju02g0844 | 1006 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 407 | 593 | - | - | |
| Alju02g0844 | 1006 | Gene3D | Transferase(Phosphotransferase) domain 1 | 740 | 960 | - | - | |
| Alju02g0844 | 1006 | Pfam | Protein kinase domain | 665 | 932 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Alju02g0844 | 1006 | Gene3D | Ribonuclease Inhibitor | 273 | 383 | IPR032675 | - | |
| Alju02g0844 | 1006 | Gene3D | Ribonuclease Inhibitor | 202 | 272 | IPR032675 | - | |
| Alju02g0844 | 1006 | SUPERFAMILY | L domain-like | 82 | 366 | - | - | |
| Alju02g0844 | 1006 | Gene3D | Phosphorylase Kinase; domain 1 | 636 | 739 | - | - | |
| Alju02g0844 | 1006 | SUPERFAMILY | Protein kinase-like (PK-like) | 648 | 937 | IPR011009 | - | |
| Alju02g0844 | 1006 | ProSiteProfiles | Leucine-rich repeat profile. | 309 | 330 | IPR001611 | GO:0005515 | |
| Alju02g0844 | 1006 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 634 | 739 | - | - | |
| Alju02g0844 | 1006 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase At1g53440 | 38 | 202 | - | - | |
| Alju02g0844 | 1006 | SMART | LRR_typ_2 | 186 | 209 | IPR003591 | - | |
| Alju02g0844 | 1006 | SMART | LRR_typ_2 | 307 | 330 | IPR003591 | - | |
| Alju02g0844 | 1006 | SMART | LRR_typ_2 | 162 | 185 | IPR003591 | - | |
| Alju02g0844 | 1006 | Pfam | Malectin domain | 409 | 588 | IPR021720 | - | |
| Alju02g0844 | 1006 | Gene3D | Ribonuclease Inhibitor | 41 | 201 | IPR032675 | - | |
| Alju02g0844 | 1006 | Gene3D | - | 406 | 593 | - | - | |
| Alju02g0844 | 1006 | MobiDBLite | consensus disorder prediction | 971 | 1006 | - | - | |
| Alju02g0844 | 1006 | Pfam | Leucine rich repeat | 164 | 222 | IPR001611 | GO:0005515 | |
| Alju02g0844 | 1006 | Pfam | Leucine rich repeat | 285 | 343 | IPR001611 | GO:0005515 | |
| Alju02g0844 | 1006 | SMART | serkin_6 | 664 | 934 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Alju02g0844 | 1006 | CDD | STKc_IRAK | 670 | 937 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Alju02g0844 | Alju-ChrAlju02 | 6276297 | 6284396 | Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Alju02g0844 | 1 | 1004 | Receptor kinase-like Gene Family | AT1G53440 | 55.024 | 0.0 | 1093 |